Adam L. Halberstadt, Ph.D. - Publications

Affiliations: 
2006 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Neuranatomy, Vestibular Neurophysiology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Roberts BZ, Minassian A, Halberstadt AL, He YV, Chatha M, Geyer MA, Grant I, Young JW. HIV transgenic rats demonstrate impaired sensorimotor gating, but are insensitive to cannabinoid (Δ9-tetrahydrocannabinol)-induced deficits. The International Journal of Neuropsychopharmacology. PMID 34338765 DOI: 10.1093/ijnp/pyab053  1
2021 Klein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, McCorvy JD, Halberstadt AL. Investigation of the Structure-Activity Relationships of Psilocybin Analogues. Acs Pharmacology & Translational Science. 4: 533-542. PMID 33860183 DOI: 10.1021/acsptsci.0c00176  1
2021 Fricke J, Sherwood AM, Halberstadt AL, Kargbo RB, Hoffmeister D. Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity. Journal of Natural Products. PMID 33667102 DOI: 10.1021/acs.jnatprod.1c00087  0.01
2021 Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, et al. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews. 73: 310-520. PMID 33370241 DOI: 10.1124/pr.118.015552  0.01
2020 Leptourgos P, Fortier-Davy M, Carhart-Harris R, Corlett PR, Dupuis D, Halberstadt AL, Kometer M, Kozakova E, LarØi F, Noorani TN, Preller KH, Waters F, Zaytseva Y, Jardri R. Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison. Schizophrenia Bulletin. PMID 32944778 DOI: 10.1093/Schbul/Sbaa117  0.01
2020 Amodeo DA, Hassan O, Klein L, Halberstadt AL, Powell SB. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice. Behavioural Brain Research. 395: 112861. PMID 32814148 DOI: 10.1016/J.Bbr.2020.112861  1
2020 Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Dowling G, Halberstadt AL. Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ). Drug Testing and Analysis. PMID 32803833 DOI: 10.1002/Dta.2911  1
2020 Halberstadt AL. Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network. Scientific Reports. 10: 8344. PMID 32433580 DOI: 10.1038/S41598-020-65264-X  0.01
2020 Brandt SD, Carlino L, Kavanagh PV, Westphal F, Dreiseitel W, Dowling G, Baumann MH, Sitte HH, Halberstadt AL. Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants. Drug Testing and Analysis. PMID 32372465 DOI: 10.1002/Dta.2813  1
2020 Castellanos JP, Woolley C, Bruno KA, Zeidan F, Halberstadt A, Furnish T. Chronic pain and psychedelics: a review and proposed mechanism of action. Regional Anesthesia and Pain Medicine. PMID 32371500 DOI: 10.1136/Rapm-2020-101273  0.01
2020 Jensen AA, Halberstadt AL, Märcher-Rørsted E, Odland AU, Chatha M, Speth N, Liebscher G, Hansen M, Bräuner-Osborne H, Palner M, Andreasen JT, Kristensen JL. The selective 5-HT receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [H]25CN-NBOH. Biochemical Pharmacology. 177: 113979. PMID 32298690 DOI: 10.1016/J.Bcp.2020.113979  1
2020 Marcher-Rørsted E, Halberstadt AL, Klein AK, Chatha M, Jademyr S, Jensen AA, Kristensen JL. Investigation of the 2,5-dimethoxy motif in phenethylamine Serotonin 2A receptor agonists. Acs Chemical Neuroscience. PMID 32212672 DOI: 10.1021/Acschemneuro.0C00129  1
2020 Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, Dowling G, Dempster NM, Wallach J, Passie T, Halberstadt AL. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Testing and Analysis. PMID 32180350 DOI: 10.1002/dta.2789  1
2020 Sherwood AM, Halberstadt AL, Klein AK, McCorvy JD, Kaylo KW, Kargbo RB, Meisenheimer P. Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin. Journal of Natural Products. PMID 32077284 DOI: 10.1021/Acs.Jnatprod.9B01061  1
2020 Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology. 107933. PMID 31917152 DOI: 10.1016/J.Neuropharm.2019.107933  1
2019 Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, Stratford A, Brandt SD. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). Neuropharmacology. 107856. PMID 31756337 DOI: 10.1016/J.Neuropharm.2019.107856  1
2019 Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL. DARK Classics in Chemical Neuroscience: NBOMes. Acs Chemical Neuroscience. PMID 31657895 DOI: 10.1021/Acschemneuro.9B00528  1
2019 Wallach J, Colestock T, Agramunt J, Claydon MDB, Dybek M, Filemban N, Chatha M, Halberstadt AL, Brandt SD, Lodge D, Bortolotto ZA, Adejare A. Pharmacological characterizations of the legal high fluorolintane and isomers. European Journal of Pharmacology. 172427. PMID 31152702 DOI: 10.1016/J.Ejphar.2019.172427  1
2019 Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Dowling G, Wallach J, Halberstadt AL. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD). Drug Testing and Analysis. PMID 31083768 DOI: 10.1002/Dta.2613  1
2019 Young JW, Geyer MA, Halberstadt AL, van Enkhuizen J, Minassian A, Khan A, Perry W, Eyler LT. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT. Bipolar Disorders. PMID 31025493 DOI: 10.1111/Bdi.12786  1
2019 Halberstadt AL, Brandt SD, Walther D, Baumann MH. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α-adrenergic receptors. Psychopharmacology. PMID 30904940 DOI: 10.1007/S00213-019-05207-1  1
2019 Halberstadt AL, Chatha M, Chapman SJ, Brandt SD. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice. Journal of Psychopharmacology (Oxford, England). 269881119826610. PMID 30789291 DOI: 10.1177/0269881119826610  1
2018 Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Psychopharmacology. PMID 30448990 DOI: 10.1007/S00213-018-5118-Y  1
2018 Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD. Correction to: Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology. PMID 30443792 DOI: 10.1007/S00213-018-5117-Z  1
2018 Halberstadt AL, Chatha M, Stratford A, Grill M, Brandt SD. Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs. Neuropharmacology. PMID 30385253 DOI: 10.1016/J.Neuropharm.2018.10.037  1
2018 Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology. PMID 30298278 DOI: 10.1007/S00213-018-5055-9  1
2018 Klein LM, Cozzi NV, Daley PF, Brandt SD, Halberstadt AL. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs. Neuropharmacology. PMID 29499272 DOI: 10.1016/J.Neuropharm.2018.02.028  1
2017 Brandt SD, Kavanagh PV, Twamley B, Westphal F, Elliott SP, Wallach J, Stratford A, Klein LM, McCorvy JD, Nichols DE, Halberstadt AL. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). Drug Testing and Analysis. PMID 28585392 DOI: 10.1002/Dta.2222  1
2017 Brandt SD, Kavanagh PV, Westphal F, Elliott SP, Wallach J, Stratford A, Nichols DE, Halberstadt AL. Return of the lysergamides. Part III: Analytical characterization of N(6) -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD). Drug Testing and Analysis. PMID 28342178 DOI: 10.1002/Dta.2196  1
2017 Halberstadt AL, Geyer MA. Effect of Hallucinogens on Unconditioned Behavior. Current Topics in Behavioral Neurosciences. PMID 28224459 DOI: 10.1007/7854_2016_466  1
2017 Halberstadt AL. Hallucinogenic Drugs: A New Study Answers Old Questions about LSD. Current Biology : Cb. 27: R156-R158. PMID 28222297 DOI: 10.1016/J.Cub.2016.12.058  0.01
2017 Halberstadt AL. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens. Current Topics in Behavioral Neurosciences. PMID 28097528 DOI: 10.1007/7854_2016_64  0.01
2016 Cope ZA, Halberstadt AL, van Enkhuizen J, Flynn AD, Breier M, Swerdlow NR, Geyer MA, Young JW. Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges. Psychopharmacology. PMID 27534540 DOI: 10.1007/S00213-016-4389-4  1
2016 Wallach J, Kang H, Colestock T, Morris H, Bortolotto ZA, Collingridge GL, Lodge D, Halberstadt AL, Brandt SD, Adejare A. Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues. Plos One. 11: e0157021. PMID 27314670 DOI: 10.1371/Journal.Pone.0157021  1
2016 Brandt SD, Kavanagh PV, Westphal F, Elliott SP, Wallach J, Colestock T, Burrow TE, Chapman SJ, Stratford A, Nichols DE, Halberstadt AL. Return of the lysergamides. Part II: Analytical and behavioural characterization of N(6) -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ). Drug Testing and Analysis. PMID 27265891 DOI: 10.1002/Dta.1985  1
2016 Halberstadt AL, Hyun J, Ruderman MA, Powell SB. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice. Pharmacology, Biochemistry, and Behavior. PMID 27236030 DOI: 10.1016/J.Pbb.2016.05.009  1
2016 Brandt SD, Kavanagh PV, Dowling G, Talbot B, Westphal F, Meyer MR, Maurer HH, Halberstadt AL. Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives. Drug Testing and Analysis. PMID 27100373 DOI: 10.1002/Dta.1974  1
2016 Halberstadt AL, Sindhunata I, Scheffers K, Flynn AD, Sharp RF, Geyer MA, Young JW. Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice. Neuropharmacology. PMID 27020041 DOI: 10.1016/J.Neuropharm.2016.03.038  1
2016 Halberstadt AL. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. Pharmacology, Biochemistry, and Behavior. PMID 26780349 DOI: 10.1016/J.Pbb.2016.01.005  1
2016 Halberstadt AL, Slepak N, Hyun J, Buell MR, Powell SB. The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents. Psychopharmacology. PMID 26758284 DOI: 10.1007/S00213-016-4203-3  1
2015 Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Hoang K, Wallach J, Halberstadt AL. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Testing and Analysis. PMID 26456305 DOI: 10.1002/Dta.1884  1
2015 Manning EE, Halberstadt AL, van den Buuse M. BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26453694 DOI: 10.1093/Ijnp/Pyv116  1
2015 Nichols DE, Sassano MF, Halberstadt AL, Klein LM, Brandt SD, Elliott SP, Fiedler WJ. N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues. Acs Chemical Neuroscience. 6: 1165-75. PMID 25547199 DOI: 10.1021/Cn500292D  1
2015 Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural Brain Research. 277: 99-120. PMID 25036425 DOI: 10.1016/J.Bbr.2014.07.016  1
2014 Greer GR, Grob CS, Halberstadt AL. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. Journal of Psychoactive Drugs. 46: 73-7. PMID 24830188 DOI: 10.1080/02791072.2013.873843  1
2014 van Enkhuizen J, Geyer MA, Halberstadt AL, Zhuang X, Young JW. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder. Journal of Affective Disorders. 155: 247-54. PMID 24287168 DOI: 10.1016/J.Jad.2013.08.041  1
2014 Halberstadt AL, Geyer MA. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology. 77: 200-7. PMID 24012658 DOI: 10.1016/J.Neuropharm.2013.08.025  1
2013 Adams WK, Halberstadt AL, van den Buuse M. Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analyses. Frontiers in Pharmacology. 4: 109. PMID 24009584 DOI: 10.3389/Fphar.2013.00109  1
2013 Halberstadt AL, Geyer MA. Serotonergic hallucinogens as translational models relevant to schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2165-80. PMID 23942028 DOI: 10.1017/S1461145713000722  1
2013 Toth M, Gresack JE, Hauger RL, Halberstadt AL, Risbrough VB. The role of PKC signaling in CRF-induced modulation of startle. Psychopharmacology. 229: 579-89. PMID 23722830 DOI: 10.1007/S00213-013-3114-9  1
2013 Halberstadt AL, Geyer MA. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology. 227: 727-39. PMID 23407781 DOI: 10.1007/S00213-013-3006-Z  1
2013 Halberstadt AL, Powell SB, Geyer MA. Role of the 5-HTâ‚‚A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology. 70: 218-27. PMID 23376711 DOI: 10.1016/J.Neuropharm.2013.01.014  1
2013 Amitai N, Weber M, Swerdlow NR, Sharp RF, Breier MR, Halberstadt AL, Young JW. A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels. Neuroscience and Biobehavioral Reviews. 37: 1139-49. PMID 23010529 DOI: 10.1016/J.Neubiorev.2012.09.007  1
2013 Halberstadt AL, Geyer MA. Neuropharmacology of Lysergic Acid Diethylamide (LSD) and Other Hallucinogens Biological Research On Addiction. 625-635. DOI: 10.1016/B978-0-12-398335-0.00061-3  1
2012 Tanaka S, Young JW, Halberstadt AL, Masten VL, Geyer MA. Four factors underlying mouse behavior in an open field. Behavioural Brain Research. 233: 55-61. PMID 22569582 DOI: 10.1016/J.Bbr.2012.04.045  1
2012 Halberstadt AL, Buell MR, Price DL, Geyer MA. Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats. Pharmacology, Biochemistry, and Behavior. 102: 88-94. PMID 22487771 DOI: 10.1016/J.Pbb.2012.03.023  1
2012 Halberstadt AL, Nichols DE, Geyer MA. Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology. 221: 709-18. PMID 22222861 DOI: 10.1007/S00213-011-2616-6  1
2011 van den Buuse M, Ruimschotel E, Martin S, Risbrough VB, Halberstadt AL. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia. Neuropharmacology. 61: 209-16. PMID 21501627 DOI: 10.1016/J.Neuropharm.2011.04.001  1
2011 Halberstadt AL, Geyer MA. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology. 61: 364-81. PMID 21256140 DOI: 10.1016/J.Neuropharm.2011.01.017  1
2011 Halberstadt AL, Lehmann-Masten VD, Geyer MA, Powell SB. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology. 215: 81-92. PMID 21153406 DOI: 10.1007/S00213-010-2115-1  1
2011 Halberstadt AL, Koedood L, Powell SB, Geyer MA. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. Journal of Psychopharmacology (Oxford, England). 25: 1548-61. PMID 21148021 DOI: 10.1177/0269881110388326  1
2010 Halberstadt AL, Geyer MA. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. Psychopharmacology. 208: 179-89. PMID 19937319 DOI: 10.1007/S00213-009-1718-X  1
2010 Halberstadt AL, Nichols DE. Serotonin and serotonin receptors in hallucinogen action Handbook of Behavioral Neuroscience. 21: 621-636. DOI: 10.1016/S1569-7339(10)70103-X  1
2010 Quednow BB, Geyer MA, Halberstadt AL. Serotonin and Schizophrenia Handbook of Behavioral Neuroscience. 21: 585-620. DOI: 10.1016/S1569-7339(10)70102-8  1
2009 Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1958-67. PMID 19322172 DOI: 10.1038/Npp.2009.29  1
2009 Halberstadt AL, Geyer MA. Habituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors. Neurobiology of Learning and Memory. 92: 243-8. PMID 18644244 DOI: 10.1016/J.Nlm.2008.05.015  1
2008 Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology. 201: 55-66. PMID 18604652 DOI: 10.1007/S00213-008-1247-Z  1
2008 Cuccurazzu B, Halberstadt AL. Projections from the vestibular nuclei and nucleus prepositus hypoglossi to dorsal raphe nucleus in rats. Neuroscience Letters. 439: 70-4. PMID 18511198 DOI: 10.1016/J.Neulet.2008.04.094  1
2008 Halberstadt AL, Balaban CD. Selective anterograde tracing of nonserotonergic projections from dorsal raphe nucleus to the basal forebrain and extended amygdala. Journal of Chemical Neuroanatomy. 35: 317-25. PMID 18434087 DOI: 10.1016/J.Jchemneu.2008.02.006  1
2007 Halberstadt AL, Balaban CD. Selective anterograde tracing of the individual serotonergic and nonserotonergic components of the dorsal raphe nucleus projection to the vestibular nuclei. Neuroscience. 147: 207-23. PMID 17507165 DOI: 10.1016/J.Neuroscience.2007.03.049  1
2006 Halberstadt AL, Balaban CD. Anterograde tracing of projections from the dorsal raphe nucleus to the vestibular nuclei. Neuroscience. 143: 641-54. PMID 16989955 DOI: 10.1016/J.Neuroscience.2006.08.013  1
2006 Halberstadt AL, Balaban CD. Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus. Neuroscience. 140: 1067-77. PMID 16600519 DOI: 10.1016/J.Neuroscience.2006.02.053  1
2003 Halberstadt AL, Balaban CD. Organization of projections from the raphe nuclei to the vestibular nuclei in rats. Neuroscience. 120: 573-94. PMID 12890525 DOI: 10.1016/S0306-4522(02)00952-1  1
1995 Halberstadt AL. The phencyclidine-glutamate model of schizophrenia. Clinical Neuropharmacology. 18: 237-49. PMID 8635182 DOI: 10.1097/00002826-199506000-00004  1
Show low-probability matches.